population health

Clinical Pathways GPS

The Future of Clinical Pathways: The Potential Impact of the Presidential Election

10/12/2016

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Scott Guerin, PhD

Although the topic of health care will continue to be a political one, the continued growth of public health care spending suggests that the government will need to continue its shift toward improving the value of...

...

10/12/2016

Journal of Clinical Pathways

Interview

Pathways for Cancer Survivors

10/12/2016

JCP Editors

Thanks to advances in medical research and more sophisticated methods of administration, cancer patients today are living longer than ever.1 Yet, while these advances have been universally celebrated by all health...

Thanks...

10/12/2016

Journal of Clinical Pathways

Research in Review

Mixed Consensus on Cardiovascular Screening Guidelines

10/12/2016

JCP Editors

Primary care physicians play an important role in the prevention of cardiovascular disease (CVD) but still find implementation of prevention strategies challenging, which may be limiting their usage. A review of...

...

10/12/2016

Journal of Clinical Pathways

Research in Review

Infectious Disease Specialists Propose Clinical Pathway for ABSSI

10/12/2016

JCP Editors

Because patients with moderate to severe acute bacterial skin and skin structure infections (ABSSI) are difficult to categorize and require thoughtful care and management, clinicians often choose costly inpatient...

...

10/12/2016

Journal of Clinical Pathways

Editor's Page

Accounting for Patient Differences in the Pathway

10/12/2016

Winston Wong, PharmD, Editor-in-Chief

At the first Clinical Pathways Congress (September 16-18; Boston, MA), the official meeting of Journal of Clinical Pathways, one of the themes that came up continuously throughout the meeting was the importance of...

At the...

10/12/2016

Journal of Clinical Pathways

Research in Review

Out-of-Pocket Costs May Delay TKI Initiation in Patients With CML

10/10/2016

JCP Editors

The significant out-of-pocket costs cancer patients face before Medicare Insurance drug benefits kick in may delay initiation of tyrosine-kinase inhibitor (TKI) therapy for chronic myeloid leukemia (CML), according...

The...

10/10/2016

Journal of Clinical Pathways

Research in Review

Patient, Policymaker Conceptions of Value in Cancer Care Differ

10/07/2016

JCP Editors

New findings presented by the Cancer Support Community suggest that a significant proportion of patients have difficulty conceptualizing value in terms of current cost-benefit models used by...

New...

10/07/2016

Journal of Clinical Pathways

Department

Better Cervical and Endometrial Cancer Outcomes With IMRT

10/03/2016

JCP Editors

Patients treated with intensity-modulated radiation therapy (IMRT) for cervical or endometrial cancer have fewer adverse events and experience better quality of life than those treated with conventional radiation...

...

10/03/2016

Journal of Clinical Pathways

Research in Review

Novel Tumor Analysis Method Identifies Aggressive Prostate Cancer

09/17/2016

JCP Editors

Despite recent advances in understanding prostate cancer heterogeneity, better methods for classification of prostate cancer are still needed. Researchers at Cedars-Sinai have developed a new method to identify which...

...

09/17/2016

Journal of Clinical Pathways

Research in Review

Neoadjuvant Chemotherapy May Be Optimal for Stage IV Ovarian Cancer

09/15/2016

JCP Editors

Primary cytoreductive surgery (PCS) may improve survival for patients with stage III ovarian cancer, while neoadjuvant chemotherapy may be the optimal treatment for patients with stage IV disease, reported...

...

09/15/2016

Journal of Clinical Pathways